TSHATAYSHA GENE THERAPIES INC
CUSIP 877619106 · common stock
4 tracked investors held TAYSHA GENE THERAPIES INC (TSHA) at the end of Q3 2026, worth $185.1M in total. The largest holder was RA Capital Management, with 1.5% of its portfolio.
Holders · Q3 2026
4
New holders
0
Value held
$185.1M
Quarter-end price (est.)
$4.87
Investors holding TSHA · Q3 2026
| Investor | Weight | Shares | Value | Change |
|---|---|---|---|---|
| RA Capital Management RA Capital Management, L.P. | 1.49% | 30,435,190 | $148.2M | ADD+29.2% |
| Julian Baker Baker Bros. Advisors LP | 0.09% | 4,004,756 | $19.5M | HOLD |
| Adar1 Capital Management ADAR1 Capital Management, LLC | 0.63% | 3,059,567 | $14.9M | ADD+0.6% |
| Polen Capital Management Polen Capital Management LLC | 0.03% | 503,379 | $2.5M | ADD+2.9% |